21 – 30 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
(
- Contribution to journal › Article
-
Mark
Non‐Apoptotic Caspase‐3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum
(
- Contribution to journal › Article
-
Mark
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
(
- Contribution to journal › Scientific review
-
Mark
The effects of virtual reality training in stroke and Parkinson’s disease rehabilitation : a systematic review and a perspective on usability
(
- Contribution to journal › Scientific review
-
Mark
Novel insights regarding the measurement properties of the SCOPA-AUT
(
- Contribution to journal › Article
- 2021
-
Mark
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases : An Overview
(
- Contribution to journal › Scientific review
-
Mark
Toxin-Based Rodent Models of Parkinson’s Disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The bacterial amyloids phenol soluble modulins from staphylococcus aureus catalyze alpha-synuclein aggregation
(
- Contribution to journal › Article